Column Group LLC Surrozen, Inc. Transaction History

Column Group LLC

$79.2 Million
Q3 2025

A detailed history of Column Group LLC transactions in Surrozen, Inc. stock. As of the latest transaction made, Column Group LLC holds 1,499,773 shares of SRZN stock, worth $18.9 Million. This represents 23.06% of its overall portfolio holdings.

Number of Shares

1,499,773

Previous 1,499,773 -0.0%

Holding current value

$18.9 Million

Previous $13.4 Million 36.14%

% of portfolio

23.06%

Previous 20.4%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$9.83 - $17.02 $6.78 Million - $11.7 Million	689,685 Added 85.14%	1,499,773 $17.5 Million
Q2 2024 Aug 15, 2024	BUY	$8.61 - $11.43 $1.67 Million - $2.21 Million	193,548 Added 31.39%	810,088 $8.87 Million
Q1 2024 May 15, 2024	SELL	$7.6 - $15.71 $84,443 - $174,553	-11,111 Reduced 1.77%	616,540 $9.69 Million
Q4 2023 Feb 09, 2024	SELL	$0.33 - $9.4 $2.9 Million - $82.6 Million	-8,787,144 Reduced 93.33%	627,651 $5.9 Million
Q2 2023 Jul 24, 2023	BUY	$0.55 - $0.72 $91,666 - $119,999	166,666 Added 1.8%	9,414,795 $5.18 Million

Q1 2023 May 15, 2023	SELL	$0.56 - $1.32 $93,332 - $219,999	-166,666 Reduced 1.77%	9,248,129 $5.55 Million
Q4 2022 Feb 13, 2023	BUY	$0.42 - $41.25 $69,999 - $6.87 Million	166,666 Added 1.8%	9,414,795 $5.46 Million
Q2 2022 Aug 12, 2022	SELL	$2.14 - $3.43 $356,665 - $571,664	-166,666 Reduced 1.77%	9,248,129 $27.7 Million
Q4 2021 Feb 11, 2022	BUY	$6.0 - $9.92 $999,996 - $1.65 Million	166,666 Added 1.8%	9,414,795 $60.6 Million
Q3 2021 Nov 12, 2021	BUY	$6.98 - $12.03 $64.6 Million - $111 Million	9,248,129 New	9,248,129 $65.5 Million

Others Institutions Holding SRZN

# of Institutions

Shares Held

5.21M

Call Options Held

Put Options Held

View Full List

About Surrozen, Inc.

Ticker SRZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,122,900
Market Cap $443M
Description
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...

More about SRZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Column Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Column Group LLC with notifications on news.

Account